NOTA: Los ensayos clínicos recogidos en esta página proceden de la base de datos ClinicalTrials.gov y contempla tan sólo aquellos cuyo estado es 1- Active, not recruiting y 2. Recruiting.
Anakinra
- NCT04362943 [España] – Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults (COVID-AGE)
.
Antivirales
- NCT04304053 [España] – Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention (HCQ4COV19)
.
Azitromicina
- NCT04332094 [España] – Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (TOCOVID)
- NCT04366245 [España] – Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
.
Baricitinib
- NCT04346147 [España] – Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 (Covid-19HUF)
- NCT04362943 [España] – Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults (COVID-AGE)
.
Células madre
- NCT04361942 [España] – Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV)
.
Defibrotida
- NCT04348383 [España] – Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. (DEFACOVID)
.
Dexametasona
- NCT04325061 [España] – Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 (DEXA-COVID19)
.
Emicitrabine/Tenofovir
- NCT04334928 [España] – Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel (EPICOS)
.
Hidroxicloroquina
- NCT04304053 [España] – Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention (HCQ4COV19)
- NCT04331834 [España] – Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic (PrEP_COVID)
- NCT04332094 [España] – Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (TOCOVID)
- NCT04334928 [España] – Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel (EPICOS)
- NCT04346147 [España] – Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 (Covid-19HUF)
- NCT04366245 [España] – Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
.
Imatinib
- NCT04346147 [España] – Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 (Covid-19HUF)
.
Inhibidores de la ECA
- NCT04367883 [España] – Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection
.
Interferón
- NCT04366245 [España] – Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
.
Lopinavir/Ritonavir
- NCT04346147 [España] – Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 (Covid-19HUF)
- NCT04366245 [España] – Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
.
Metilprednisolona
- NCT04329650 [España] – Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia
- NCT04341038 [España] – Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury (TACROVID)
.
Pembrolizumab
- NCT04335305 [España] – Checkpoint Blockade in COVID-19 Pandemic (COPERNICO)
.
Plasma
- NCT04345523 [España] – Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients (ConPlas-19)
- NCT04366245 [España] – Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
.
Ruxolitinib
- NCT04348695 [España] – Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.
..
Sarilumab
- NCT04357808 [España] – Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) (SARCOVID)
.
Siltuximab
- NCT04329650 [España] – Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia
.
Tacrolimus
- NCT04341038 [España] – Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury (TACROVID)
.
Tocilizumab
- NCT04332094 [España] – Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (TOCOVID)
- NCT04335305 [España] – Checkpoint Blockade in COVID-19 Pandemic (COPERNICO)
Coronavirus: recursos de información 